Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally Farouk

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Microbial Pathogenesis|November 29, 2021
The impact of genetic variations in sofosbuvir metabolizing enzymes and innate immunity mediators on treatment outcome in HCV-infected patientsMarwa K Ibrahim, Mohamed AbdElrahman, Noha G Bader El Din, et al.
World Journal of Gastroenterology|September 29, 2016
Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patientsNoha G Bader El Din, Sally Farouk, Reem El-Shenawy, et al.
Journal, Genetic Engineering & Biotechnology|December 12, 2025
Assessment of peripheral gene expression signatures as predictive biomarkers for hepatocellular carcinoma following DAA treatmentRehab I Moustafa, Sally Farouk, Noha G Bader El Din, et al.
Infectious Agents and Cancer|February 20, 2026
SOX9 and TNFAIP3 dysregulation in HCV-associated HCC after DAA therapy: insights into post-viral oncogenic memoryRehab I Moustafa, Sally Farouk, Hassan Elsayed, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Microbial Pathogenesis|November 29, 2021
The impact of genetic variations in sofosbuvir metabolizing enzymes and innate immunity mediators on treatment outcome in HCV-infected patientsMarwa K Ibrahim, Mohamed AbdElrahman, Noha G Bader El Din, et al.
World Journal of Gastroenterology|September 29, 2016
Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patientsNoha G Bader El Din, Sally Farouk, Reem El-Shenawy, et al.
Journal, Genetic Engineering & Biotechnology|December 12, 2025
Assessment of peripheral gene expression signatures as predictive biomarkers for hepatocellular carcinoma following DAA treatmentRehab I Moustafa, Sally Farouk, Noha G Bader El Din, et al.
Infectious Agents and Cancer|February 20, 2026
SOX9 and TNFAIP3 dysregulation in HCV-associated HCC after DAA therapy: insights into post-viral oncogenic memoryRehab I Moustafa, Sally Farouk, Hassan Elsayed, et al.
Pageof 2